IRIS
CARUBBI, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.560
EU - Europa 963
AS - Asia 358
OC - Oceania 4
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 1
Totale 2.890
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.555
IE - Irlanda 344
CN - Cina 207
SE - Svezia 202
TR - Turchia 119
IT - Italia 93
DE - Germania 90
UA - Ucraina 80
GB - Regno Unito 60
FR - Francia 35
BE - Belgio 27
FI - Finlandia 26
IN - India 14
VN - Vietnam 12
CA - Canada 4
NL - Olanda 3
AU - Australia 2
EU - Europa 2
NZ - Nuova Zelanda 2
AL - Albania 1
BR - Brasile 1
CH - Svizzera 1
CI - Costa d'Avorio 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
LB - Libano 1
MX - Messico 1
PH - Filippine 1
RU - Federazione Russa 1
ZA - Sudafrica 1
Totale 2.890
Salva come PNG Salva come JPEG
Città #
Chandler 396
Dublin 337
Jacksonville 312
Ann Arbor 106
Izmir 89
New York 66
Nanjing 54
Boardman 52
Wilmington 48
Lawrence 47
Princeton 47
Woodbridge 38
Ashburn 37
Dearborn 36
Beijing 34
L'aquila 33
Brussels 27
San Mateo 23
Nanchang 18
Milan 17
Los Angeles 16
Dong Ket 12
Seattle 12
Verona 12
Des Moines 10
Grafing 10
L’Aquila 10
Hebei 9
Jiaxing 9
Kunming 9
Shenyang 9
Tianjin 9
Bremen 8
Jinan 8
Mountain View 8
Ningbo 7
Hangzhou 6
Changsha 5
Helsinki 5
Hefei 4
Pune 4
Shanghai 4
Aquila 3
Edinburgh 3
Falls Church 3
Naples 3
Taizhou 3
Zhengzhou 3
Auckland 2
Cedar Knolls 2
Changchun 2
Guangzhou 2
Houston 2
Intra 2
Jinhua 2
Lanzhou 2
Norwalk 2
Orange 2
Pescara 2
Tappahannock 2
Washington 2
Auburn Hills 1
Bandung 1
Basel 1
Bournemouth 1
Brisbane 1
Central District 1
Centurion 1
Chongqing 1
Città di Castello 1
Fairfield 1
Fremont 1
Harbin 1
Isernia 1
Kish 1
Kocaeli 1
Manila 1
Melbourne 1
Montreal 1
Mumbai 1
Navirai 1
New Delhi 1
Odesa 1
Paris 1
Philadelphia 1
Redwood City 1
Rome 1
San Francisco 1
Smithers 1
Suzhou 1
Taiyuan 1
Thunder Bay 1
Tirana 1
Vancouver 1
Ürümqi 1
Totale 2.081
Salva come PNG Salva come JPEG
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 109
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 97
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 93
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 91
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 87
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 87
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 86
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 83
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 83
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 79
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 77
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 76
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 74
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 74
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 71
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 70
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 69
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 68
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 67
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 67
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 67
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 65
Interstitial lung disease in systemic sclerosis: current and future treatment. 64
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 62
The Need to Target Mucosa-Associated Lymphoid Tissue for Preventing Lymphoma in Rheumatoid Factor-Positive Patients with Sjögren's Syndrome: Comment on the Article by Nocturne et al 61
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 60
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 59
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 59
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 56
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 55
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 55
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 52
Diet in rheumatoid arthritis versus systemic lupus erythematosus: Any differences? 52
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 52
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 49
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 49
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 48
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 48
Evaluation of the performance of Dutch Lipid Clinic Network score in an Italian FH population: The LIPIGEN study 46
Pericarditis after sars‐cov‐2 infection: Another pebble in the mosaic of long covid? 43
Adherence to the Mediterranean diet and the impact on clinical features in primary Sjögren's syndrome 40
Safety and efficacy of certolizumab pegol in a real-life cohort of patients with psoriasis and psoriatic arthritis 39
Blood Pressure Profiles and Cognitive Function from Adulthood to Old Age: Chasing a Golden Middle Way? 39
Certolizumab pegol for the treatment of psoriatic arthritis and plaque psoriasis 36
Ferritin is associated with the severity of lung involvement but not with worse prognosis in patients with COVID-19: data from two Italian COVID-19 units 36
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 34
Potential of stem cells in the treatment of rheumatic disease 27
The URRAH study 16
Immune-mediated inflammatory diseases after anti-SARS-CoV-2 vaccines: new diagnoses and disease flares 13
Electrocardiographic Abnormalities in Hospitalized Patients with COVID-19 and the Associations with Clinical Outcome 7
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC) 5
Different clinical presentations of primary Sjögren's syndrome: Not only a matter of age. Comment on: “Elderly-onset primary Sjögren's syndrome focused on clinical and salivary gland ultrasonographic features by Lee et al. Joint Bone Spine. 2021;88:105132” 5
The Interplay between Cardiovascular Risk, Cardiovascular Events, and Disease Activity in Primary Sjögren’s Syndrome: Is Uric Acid the Missing Link? 4
SpA plus IBD or IBD plus SpA: Does commutative property apply? 2
Derivation and validation of four patient clusters in Still’s disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease Registry 1
Still's disease continuum from childhood to elderly: data from the international AIDA Network Still's disease registry 1
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 1
Totale 3.016
Salva come PNG Salva come JPEG
Categoria #
all - tutte 10.812
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.812
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019117 0 0 0 0 0 0 0 0 0 0 3 114
2019/2020411 61 5 43 10 5 64 70 19 43 17 3 71
2020/2021419 15 43 0 55 49 22 56 4 47 28 66 34
2021/2022397 24 10 97 41 9 18 7 18 20 36 25 92
2022/20231.040 82 84 18 138 81 104 1 52 428 9 26 17
2023/2024230 41 13 14 18 22 89 4 12 2 15 0 0
Totale 3.016